TAZ Antikörper (C-Term)
-
- Target Alle TAZ Antikörper anzeigen
- TAZ (Tafazzin (TAZ))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TAZ Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Tafazzin
- Sequenz
- HLKTQAEQLH NH
- Spezifität
- This antibody is expected to recognise isoforms 1to 4 (NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1, respectively).
- Kreuzreaktivität
- Hund, Human, Maus, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1.
- Isotyp
- IgG
- Top Product
- Discover our top product TAZ Primärantikörper
-
anti-Tafazzin (TAZ) (AA 1-262) antibody
TAZ Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1B10 unconjugated
anti-Tafazzin (TAZ) (AA 32-60) antibodyTAZ Reaktivität: Human WB, ELISA, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 1-100) antibodyTAZ Reaktivität: Human, Maus, Ratte WB, ELISA, IF (cc), IF (p), FACS, ICC, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 32-60), (N-Term) antibodyTAZ Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB21836 unconjugated
anti-Tafazzin (TAZ) (AA 46-240) antibodyTAZ Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 95-262) antibodyTAZ Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 154-292) antibodyTAZ Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tafazzin (TAZ) antibodyTAZ Reaktivität: Human, Maus WB, BI Wirt: Maus Monoclonal M2-616 unconjugated
anti-Tafazzin (TAZ) (AA 1-262) antibodyTAZ Reaktivität: Human ELISA, IF Wirt: Maus Monoclonal 3C10 unconjugated
anti-Tafazzin (TAZ) (AA 46-239) antibodyTAZ Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot: Approx 28 kDa band observed in Human Heart lysates (calculated MW of 33.5 kDa according to NP_000107.1, 30.2 kDa according to NP_851828.1, 31.7 kDa according to NP_851829.1 and 28.5 according to NP_851830.1). Recommended concentration: 0.3-1.0
Peptide ELISA: antibody detection limit dilution 1:32000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- TAZ (Tafazzin (TAZ))
- Andere Bezeichnung
- TAZ (TAZ Produkte)
- Hintergrund
- TAZ, tafazzin (cardiomyopathy, dilated 3A (X-linked) endocardial fibroelastosis 2 Barth syndrome) , HGNC:11577, BTHS, CMD3A, EFE, EFE2, G4.5, XAP-2 , OTTHUMP00000061673, cardiomyopathy, dilated 3A (X-linked), tafazzin, XX-FW83563B9.3, FLJ27390, Taz1, LVNC
- Gen-ID
- 6901
- NCBI Accession
- NP_000107, NP_851828, NP_851829, NP_851830
-
